ACE2 and COVID-19: With the capacity of quantitatively detecting stable and transient ACE2 expression non‐invasively, this quantitative imaging method may have utility to evaluate differences across patients for SARS‐CoV‐2 infectivity; COVID‐19 symptom severity and duration; and for evaluation of physiological effects from other emerging and novel coronaviruses.